EUCTR2004-002539-25-IT进行中（未招募）不适用
Randomized phase II trial of second-line chemotherapy with oxaliplatin and docetaxel vs. docetaxel in patients with advanced non-small cell lung cancer (NSCLC)
IVERSITA' DEGLI STUDI DI UDINE0 个研究点目标入组 42 人开始时间: 2005年2月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Randomized phase II trial of first line chemoterapy Docetaxel given in combination with Cisplatin for 6 cycles or Docetaxel given in combination with Cisplatin for 3 cycles followed by Docetaxel alone for 3 cycles in patients with advanced non-small-cell lung cancer. - NDPatients with advanced non-small-cell lung cancerMedDRA version: 9.1Level: LLTClassification code 10026532Term: Malignant neoplasm of thoraxEUCTR2007-002625-77-ITFONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO
进行中（未招募）
不适用
Randomized phase II trial on primary chemotherapy with high-dose methotrexate and high-dose cytarabine with or without thiotepa, and with or without rituximab, followed by brain irradiation vs. high-dose chemotherapy supported by autologous stem cells transplantation for immunocompetent patients with newly diagnosed primary cns lymphoma. - IELSG 32newly diagnosed primary CNS lymphoma in immunocompetent patientsMedDRA version: 9.1Level: LLTClassification code 10036685EUCTR2009-012432-32-ITIELSG-International Extranodal Lymphoma Study Group126
进行中（未招募）
不适用
Et randomiseret fase ll studie af primær kemoterapi med højdosis Methotrexat oghøjdosis Cytarabin med eller uden thiotepa og med eller uden Rituximab efterfulgtaf strålebehandling eller højdosis kemoterapi med autolog stamcelletransplantationhos immunkompetente patienter med nydiagnosticeret primært CNS-lymfom.ewly diagnosed Primary CNS LymphomaEUCTR2009-012432-32-DKInternational Extranodal Lymphoma Srudy Group IELSG126
进行中（未招募）
不适用
Klinisk prövning med kombinationsbehandling av kemoterapi och antikroppar för behandling av patienter med gallgångscancer som inte kan opereras.EUCTR2010-020385-13-SEVejle Hospital78
进行中（未招募）
1 期
Randomized phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable cholangiocarcinoma without KRAS mutations - GOC-B-PEUCTR2010-020385-13-DKVejle Hospital